News

Featured News

  • 2023 |
  • 2022 |
  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • Press Release | January 22, 2023

    Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast 320 mg was Well Tolerated and Achieved Statistically Significant FVC Increase in Patients with Idiopathic Pulmonary Fibrosis

    Read More

    Press Release | January 18, 2023

    Freenome Partners with Geisinger for the Sanderson Study

    Read More

    Education | January 12, 2023

    Agent Capital’s Associate, Jonathan Ark’s PhD Work Published in Cell

    Read More

    Press Release | January 11, 2023

    Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD)

    Read More